Loose Seton Prior to Surgery for Single-tract Cryptoglandular Fistula vs no Seton
SETON
1 other identifier
interventional
277
1 country
2
Brief Summary
Cryptoglandular anal fistulas can cause pain, discharge, recurrent infection, and a prolonged treatment course. In current practice, patients with a single-tract mid-high or high cryptoglandular anal fistula often first undergo placement of a loose seton before definitive sphincter-preserving surgery. Although this staged approach is widely used, high-quality evidence showing that preoperative seton placement improves healing or other patient outcomes is limited. The SETON trial is a multicenter, randomized, controlled non-inferiority trial that compares two accepted treatment strategies: loose seton placement for approximately 8 weeks followed by definitive sphincter-preserving surgery versus direct sphincter-preserving surgery without prior seton placement. The study aims to determine whether omitting routine seton placement is not inferior in terms of fistula closure 26 weeks after the final surgical intervention. Secondary outcomes include recurrence, postoperative complications, re-interventions, pain, continence, fistula-related quality of life, generic quality of life, return to work, and healthcare and societal costs. The results of this trial may help determine whether a routinely used treatment step can be safely omitted, potentially reducing treatment burden, shortening the treatment pathway, and lowering costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 6, 2026
CompletedFirst Posted
Study publicly available on registry
September 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
September 8, 2026
September 1, 2026
2 years
May 6, 2026
September 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Fistula healing
Fistula closure is defined as absence of an external opening or discharge on physical examination 26 weeks after the final surgical intervention. In case of clinical uncertainty, closure will be confirmed by magnetic resonance imaging (MRI) or endoanal ultrasound.
26 weeks
Study Arms (2)
Seton placement prior to surgery
NO INTERVENTIONNo seton placement prior to surgery
EXPERIMENTALInterventions
No seton placement prior to sfincter preserving surgery
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Single-tract non-purulent mid-high or high cryptoglandular anal fistula
- Eligible for sphincter-preserving surgical treatment
- Able to complete Dutch-language questionnaires sent by email
- Written informed consent provided
You may not qualify if:
- Anorectal abscess
- Multiple or complex anorectal fistulas
- Inflammatory bowel disease or clinical suspicion requiring further investigation
- History of anorectal malignancy
- Use of immunosuppressive medication at the time of surgery
- History of pelvic radiation
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Proctos Klinieklead
Study Sites (2)
Ziekenhuis Amstelland
Amstelveen, North Holland, 1186 AM, Netherlands
Proctos Kliniek
Bilthoven, North Holland, 3723 MB, Netherlands
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 6, 2026
First Posted
September 8, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2029
Last Updated
September 8, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 3 months embargo due to publishing.
- Access Criteria
- There will be access restrictions to my data collection. A request must be made at Data Access Committee (DAC).
(Several versions of) processed data, documentation of the research process, including deindentified participant data, raw data, syntaxes